Bala Mohan

Insider CIK 1991787 · MRSN SVP, Chief Development Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	1,853	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	9,309	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	700	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	1,190	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	5,246	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	1,053	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	2,646	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	7,734	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	3,515	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	2,500	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	D To issuer deriv	2026-01-06	2026-01-06	1,750	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	U Tender	2026-01-06	2026-01-06	2,927	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2025-10-27	2025-10-28	77	$9.90	$762	2,922	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2025-10-25	2025-10-28	250	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2025-10-25	2025-10-28	250	—	$0	2,999	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2025-01-16	2025-01-17	5,939	$0.58	$3.4K	68,872	SEC↗
MRSN Mersana Therapeutics, Inc.	A Award deriv	2025-01-15	2025-01-17	62,500	—	$0	62,500	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2025-01-15	2025-01-17	14,583	—	$0	43,750	SEC↗
MRSN Mersana Therapeutics, Inc.	A Award deriv	2025-01-15	2025-01-17	281,250	—	$0	281,250	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2025-01-15	2025-01-17	14,583	—	$0	74,811	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2025-01-14	2025-01-15	3,253	$0.66	$2.1K	60,228	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2025-01-13	2025-01-15	8,750	—	$0	17,500	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2025-01-13	2025-01-15	8,750	—	$0	63,481	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2024-10-28	2024-10-29	1,884	$1.90	$3.6K	54,731	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2024-10-25	2024-10-29	6,250	—	$0	6,250	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2024-10-25	2024-10-29	6,250	—	$0	56,615	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2024-10-03	2024-10-07	5,598	$1.96	$11.0K	50,365	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2024-10-02	2024-10-07	8,089	$2.00	$16.2K	55,963	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2024-10-01	2024-10-07	50,000	—	$0	0	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2024-10-01	2024-10-07	50,000	—	$0	64,052	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2024-01-16	2024-01-17	3,431	$2.71	$9.3K	14,052	SEC↗
MRSN Mersana Therapeutics, Inc.	A Award deriv	2024-01-15	2024-01-17	58,333	—	$0	58,333	SEC↗
MRSN Mersana Therapeutics, Inc.	A Award deriv	2024-01-15	2024-01-17	262,500	—	$0	262,500	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2024-01-13	2024-01-17	8,750	—	$0	26,250	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2024-01-13	2024-01-17	8,750	—	$0	17,483	SEC↗
MRSN Mersana Therapeutics, Inc.	S Sale	2023-10-26	2023-10-27	1,912	$1.13	$2.2K	8,733	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise deriv	2023-10-25	2023-10-27	6,250	—	$0	12,500	SEC↗
MRSN Mersana Therapeutics, Inc.	M Exercise	2023-10-25	2023-10-27	6,250	—	$0	10,645	SEC↗